South Korean company Iveam Technology took part in K-Brain 2026, where it presented a platform for imaging living brain tissue, according to 라포르시안. The company described the technology as a biological brain imaging platform during a luncheon seminar held as part of the event, 라포르시안 reported.
Coverage of the seminar highlighted the idea of exploring a living brain in real time. 한국경제 reported that the session was held successfully, describing the presentation as covering real-time exploration of the living brain. 뉴시스 also carried the company's message that it introduced its biological brain imaging platform at the event.
A separate report from 미디어데일, listed alongside the K-Brain coverage, described work using non-invasive electroceutical technology to confirm a synchronization phenomenon between neurovascular and autonomic nervous activity, and framed it as laying groundwork for glymphatic research. The source material does not state whether this work is connected to Iveam Technology's presentation, so no link between the two should be assumed.
The reports do not include technical specifications, clinical results, or details of any partnerships tied to the platform. What is clear from the coverage is that Iveam Technology used the K-Brain 2026 seminar to position its imaging work in front of an audience focused on brain research.
Watch for further disclosures from Iveam Technology on how the platform performs and whether the company reports any research or commercial collaborations.
